I am delighted to announce the formation of a new PVRI Task Force which brings together academe with the pharmaceutical industry in a unique partnership supporting our desire to help deliver new therapies for our patients.
The inaugural meeting proposing this collaboration took place in Bethesda DC at the Drug Discovery Meeting. There was unanimous support for this venture from Industry and, so, our Task Force was born. All relevant companies will be invited to nominate two senior representatives and we are currently selecting the first three priorities for action. The second face-to-face meeting will be held in Miami at our annual meeting. I believe this venture represents a major step forward for PVRI and illustrates the regard in which we, as a charitable scientific organisation, are viewed.